Butyloctyl salicylate does not have a clear safety profile for use during pregnancy, and at least one regulatory body has specifically recommended against it. Australia’s Therapeutic Goods Administration has advised that butyloctyl salicylate should not be used by pregnant women or children under four. The concern centers on its relationship to salicylic acid, a compound with known risks to fetal development when absorbed in significant amounts.
What Butyloctyl Salicylate Actually Does
Butyloctyl salicylate is an ester of salicylic acid used in sunscreens and skincare products. It is not a UV filter itself. Instead, it works as an SPF booster, helping other sun-protective ingredients perform better. It also functions as a skin-conditioning agent and solvent, giving products a smoother feel and helping dissolve other active ingredients. You will find it listed on labels of both chemical and some mineral sunscreens, sometimes at concentrations as high as 10% in leave-on products.
The Cosmetic Ingredient Review (CIR) Expert Panel, which evaluates cosmetic ingredients in the United States, has concluded that butyloctyl salicylate is safe in cosmetics when formulated to be non-irritating and non-sensitizing. That general safety assessment, however, was not pregnancy-specific.
The Salicylic Acid Connection
The pregnancy concern comes down to what happens after butyloctyl salicylate absorbs through your skin. As a salicylate ester, it can be broken down by enzymes in the body into salicylic acid, the same compound found in aspirin and many acne treatments. Not all salicylate esters release salicylic acid at the same rate. A 2024 study published in Archives of Toxicology found that different salicylates vary considerably in how much salicylic acid they produce, depending on their chemical properties and how readily they penetrate skin. Butyloctyl salicylate’s relatively small molecular size means it absorbs through the skin and enters the bloodstream.
The European Commission has flagged this issue directly, initiating a project to identify which salicylates used in cosmetics get metabolized into salicylic acid in humans. Researchers are now grouping these chemicals based on how much systemic salicylic acid exposure they actually create, because the differences between salicylate esters turn out to be significant.
Why Salicylates Raise Concerns in Pregnancy
Salicylic acid belongs to the same drug class as aspirin (acetylsalicylic acid) and other non-steroidal anti-inflammatory drugs. The FDA has warned that NSAIDs should be avoided at 20 weeks of pregnancy and later because they can reduce amniotic fluid levels. At around 30 weeks, these compounds carry the additional risk of causing premature closure of the ductus arteriosus, a critical blood vessel in the fetal heart that needs to stay open until birth.
A single application of sunscreen containing butyloctyl salicylate would not deliver anything close to an oral dose of aspirin. The CIR panel noted that even simultaneous use of several salicylic acid products would likely produce exposures lower than a baby aspirin, which is generally considered below the threshold for reproductive harm. But that assessment assumed typical use patterns. A sunscreen applied generously over the entire body once or twice daily, at concentrations up to 10%, represents a different exposure scenario, one that the CIR review itself flagged as a concern for pregnant women using high-concentration leave-on products.
What Regulators Have Said
Regulatory positions vary by country. The U.S. FDA has not issued a specific restriction on butyloctyl salicylate in cosmetics for pregnant women. The CIR panel’s general safety conclusion covers the ingredient broadly but does not address pregnancy as a separate use case in detail.
Australia’s Therapeutic Goods Administration took a more cautious approach in a 2006 assessment, concluding that butyloctyl salicylate should not be used by pregnant women. This remains the most direct regulatory statement on the topic. The reasoning aligns with the broader concern: when a leave-on product is applied over large areas of skin daily, the cumulative absorption of salicylate may reach levels worth avoiding during pregnancy.
Mineral Sunscreens as an Alternative
If you want to avoid butyloctyl salicylate during pregnancy, look for sunscreens that rely solely on zinc oxide or titanium dioxide as their active ingredients and do not include butyloctyl salicylate in the inactive ingredient list. These mineral filters sit on the skin’s surface and are not absorbed into the bloodstream in meaningful amounts.
Reading the label carefully matters here, because some sunscreens marketed as “mineral” still include butyloctyl salicylate as an SPF booster among their inactive ingredients. The active ingredient panel will list zinc oxide or titanium dioxide, but butyloctyl salicylate may appear lower in the full ingredient list. A truly mineral-only formula will not contain it.
Sun protection during pregnancy is still important. Hormonal changes make skin more prone to hyperpigmentation, and UV exposure can worsen melasma. Choosing a mineral sunscreen without salicylate-based boosters lets you maintain that protection without the uncertainty around salicylate absorption.